Provided by Tiger Trade Technology Pte. Ltd.

Pharvaris N.V.

31.19
+0.18000.58%
Post-market: 31.190.00000.00%19:50 EDT
Volume:591.39K
Turnover:18.44M
Market Cap:2.18B
PE:-10.42
High:31.55
Open:31.21
Low:30.69
Close:31.01
52wk High:43.25
52wk Low:20.65
Shares:69.86M
Float Shares:44.23M
Volume Ratio:0.89
T/O Rate:1.34%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-2.9943
EPS(LYR):-3.4871
ROE:-70.46%
ROA:-42.32%
PB:6.43
PE(LYR):-8.94

Loading ...

Pharvaris publishes patient-reported outcomes presentation on clinical evidence in HAE trials

Reuters
·
Jun 12

Pharvaris announces annual shareholder meeting

Reuters
·
Jun 11

A Look At Pharvaris (PHVS) Valuation As Deucrictibant Data Advances Toward Key EAACI 2026 Catalyst

Simply Wall St.
·
Jun 07

The Bull Case For Pharvaris (PHVS) Could Change Following New Deucrictibant Phase 3 Data Disclosures

Simply Wall St.
·
May 31

Pharvaris to present Phase 3 RAPIDe-3 end-of-progression data for oral deucrictibant in hereditary angioedema at EAACI 2026

Reuters
·
May 29

Pharvaris Principal Accounting Officer Anna Nijdam disposes of common shares worth $224,207.69

Reuters
·
May 27

Pharvaris director Elisabeth Bjork disposes 10,000 common shares for $293,166

Reuters
·
May 23

Pharvaris Chief Commercial Officer Wim Souverijns sells 10,000 shares for $299,163

Reuters
·
May 20

Pharvaris price target raised to $33 from $31 at BofA

TIPRANKS
·
May 15

Pharvaris (PHVS) Receives a Buy from H.C. Wainwright

TIPRANKS
·
May 14

Analysts’ Opinions Are Mixed on These Healthcare Stocks: Pharvaris (PHVS) and Allogene Therapeutics (ALLO)

TIPRANKS
·
May 14

Stock Track | Pharvaris N.V. Soars 5.09% Intraday on Bullish Analyst Ratings

Stock Track
·
May 14

Pharvaris Is Maintained at Market Outperform by Citizens

Dow Jones
·
May 13

Analysts Offer Insights on Healthcare Companies: Pharvaris (PHVS), Neurogene (NGNE) and Stereotaxis (STXS)

TIPRANKS
·
May 13

RBC Capital Reaffirms Their Buy Rating on Pharvaris (PHVS)

TIPRANKS
·
May 13

Calendar of U.S. Earnings Expected in the Week Ahead

Dow Jones
·
May 13

Pharvaris price target lowered to $74 from $75 at Citizens

TIPRANKS
·
May 13

Pharvaris Q1 EPS $(0.69) Beats $(0.77) Estimate

Benzinga Earnings
·
May 13

Pharvaris Q1 Loss Narrows

MT Newswires Live
·
May 13

Earnings Flash (PHVS) Pharvaris Posts Q1 Per Share Loss 0.59 Euro, vs. FactSet Est of 0.71 Euro Loss

MT Newswires Live
·
May 13